Study Examines Effects of Socioeconomics on Health of Youngsters
Children with cystic fibrosis (CF) who live in more socioeconomically disadvantaged areas of the U.S. tend to have worse lung function...
New strategy to accelerate diagnosis and improve treatment of rare diseases
Rare Disease Framework sets out vision to improve the lives of more than 3.5 million people with rare diseases in the UK The framework...
Small Study Shows Tobramycin Safely Treats Lung Infection in Infants With CF
Inhaled antibiotic tobramycin safely eradicated early Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients younger than a...
Arcturus to Develop ARCT-032 as RNA Therapy for CF
Arcturus Therapeutics has selected ARCT-032, an aerosolized RNA-based therapy, to be developed as a novel therapeutic candidate for...
FDA Expands Use of Three Cystic Fibrosis Medications
The Food and Drug Administration (FDA) has expanded the approval of Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor; Vertex),...
MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Swiss biotech Polyphor’s first-in-human phase I study...
Antifungal drug improves key cystic fibrosis biomarkers in clinical study
A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with...
Potential Antibiotic Appears to Effectively Treat M. abscessus Infections
A newly developed antibiotic, called T405, appears to effectively kill Mycobacteroides abscessus, a difficult-to-treat bacteria that can...
Production Increases for Pyocin S5, Potential Antibiotic for Treating Lung Disease
Project GAIA, establishing a large-scale manufacturing process for Pyocin S5, an investigational antibiotic for the treatment of lung...
Antifungal drug improves key cystic fibrosis biomarkers in clinical study
CHICAGO, Dec. 18 (Xinhua) -- A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in...
